Sly Saint
Senior Member (Voting Rights)
New tweet today from Paul Garner:
He has added this link to the tweet:
https://www.bmj.com/content/371/bmj.m4774/rapid-responses
Re: Updated NICE guidance on chronic fatigue syndrome
Dear Editor
Professors Turner-Stokes and Wade’s analysis of the unfitness of NICE’s evidence evaluation methods when applied to bespoke individual treatment programmes is shrewd, and their comparison of ME/CFS holistic rehabilitation to a well-tailored suit, fitted to the person, is amusing and apt.
However, neither their article nor the current NICE guideline addresses the issue that many people diagnosed with this condition might not need a suit. They might need medication.
The prevalence of ME/CFS, according to research cited in the BMJ’s recently updated ‘Best Practice’ feature, is 30.5% in the population. Nearly one person in three, if this is to be believed. This equates to 20 million, a deeply disquieting number of people for whom there are ‘no objective diagnostic tests . . . no curative treatment’ and for whom the primary goals of treatment are to give patients techniques for husbanding what little energy they possess. Their lives are limited and drab, and can scarcely be called more than existence.
where on earth did they get that figure from?